BioTuesdays

Category - Executive Moves

ArcherDX Logo

ArcherDX names Mark Massaro as CFO

Closely-held ArcherDX appointed research industry veteran, Mark Massaro, as its CFO. “Mark’s extensive knowledge of the diagnostics landscape, coupled with his more than 20 years of industry experience, is...

Zenabis

Zenabis names Kevin Coft as interim CEO

Zenabis Global (TSX:ZENA) appointed Kevin Coft as interim CEO, effective immediately, replacing Andrew Grieve, whose contract was set to expire shortly. While Mr. Grieve will be returning to his investment business, he...

Ventripoint Diagnostics

Ventripoint names Justin Leushner as CEO

Ventripoint Diagnostics (TSXV:VPT; OTC:VPTDF) appointed Justin Leushner as CEO, replacing Dr. George Adams, who was elected chairman of the board. Mr. Leushner, who was named president of Ventripoint in September, has a...

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.